AbbVie

0
Emails

AbbVie is a global biopharmaceutical company specializing in research and development of advanced therapies for complex diseases such as immunology, oncology, and neuroscience.

Tracking

Track Brand

Frequently Sends

Thursday

Common Send Time

6-8 AM

Links Per Email Avg

18

Links

Images Per Email Avg

6

Images

Sender Addresses

4 Emails Used

Get Brand Highlights

Understand their sending frequency, number of links, sender address and more.

AbbVie

Visit Website
0
Emails
AbbVie Press Release: SkinMedica® Celebrates 25 Years of Empowering Radiant Skin
June 6, 2024
Promotional
AbbVie Press Release: AbbVie to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
June 3, 2024
Business and Collaboration Outreach
AbbVie Press Release: AbbVie Receives Positive CHMP Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis
May 30, 2024
Product Announcements
AbbVie Press Release: AbbVie Completes Acquisition of Landos Biopharma
May 23, 2024
Business and Collaboration Outreach
Email validation for AbbVie Public Affairs Newsroom required
May 22, 2024
Transactional

Upgrade to track a brand

To track a brand and get insights you must upgrade.